The Pirbright Institute, Ash Road, Woking GU24 0NF, Surrey, UK.
Viruses. 2021 Dec 3;13(12):2433. doi: 10.3390/v13122433.
Foot-and-mouth disease, caused by foot-and-mouth disease virus (FMDV), is an economically devastating disease affecting several important livestock species. FMDV is antigenically diverse and exists as seven serotypes comprised of many strains which are poorly cross-neutralised by antibodies induced by infection or vaccination. Co-infection and recombination are important drivers of antigenic diversity, especially in regions where several serotypes co-circulate at high prevalence, and therefore experimental systems to study these events in vitro would be beneficial. Here we have utilised recombinant FMDVs containing an HA or a FLAG epitope tag within the VP1 capsid protein to investigate the products of co-infection in vitro. Co-infection with viruses from the same and from different serotypes was demonstrated by immunofluorescence microscopy and flow cytometry using anti-tag antibodies. FLAG-tagged VP1 and HA-tagged VP1 could be co-immunoprecipitated from co-infected cells, suggesting that newly synthesised capsids may contain VP1 proteins from both co-infecting viruses. Furthermore, we provide the first demonstration of trans-encapsidation of an FMDV genome into capsids comprised of proteins encoded by a co-infecting heterologous virus. This system provides a useful tool for investigating co-infection dynamics in vitro, particularly between closely related strains, and has the advantage that it does not depend upon the availability of strain-specific FMDV antibodies.
口蹄疫是由口蹄疫病毒(FMDV)引起的,是一种经济上极具破坏性的疾病,影响着几种重要的家畜物种。FMDV 具有高度的抗原多样性,存在 7 种血清型,由许多株组成,这些株之间的交叉中和作用很差,由感染或接种引起的抗体诱导。共同感染和重组是抗原多样性的重要驱动因素,特别是在几种血清型同时高流行的地区,因此在体外研究这些事件的实验系统将是有益的。在这里,我们利用含有 HA 或 FLAG 表位标签的重组 FMDV,研究了体外共同感染的产物。通过免疫荧光显微镜和使用抗标签抗体的流式细胞术证实了来自同一血清型和不同血清型的病毒的共同感染。来自共同感染细胞的 FLAG 标记 VP1 和 HA 标记 VP1 可被共同免疫沉淀,表明新合成的衣壳可能含有来自两种共同感染病毒的 VP1 蛋白。此外,我们首次证明了 FMDV 基因组可将包膜转移到由共同感染的异源病毒编码的蛋白组成的衣壳中。该系统为研究体外共同感染动力学提供了有用的工具,特别是在密切相关的菌株之间,并且具有不依赖于特定 FMDV 抗体可用性的优势。